Intake of oligoelements with cytarabine or etoposide alters dopamine levels and oxidative damage in rat brain.

Authors: Guzmán, David Calderón¹ (AUTHOR), Brizuela, Norma Osnaya¹ (AUTHOR), Herrera, Maribel Ortíz² (AUTHOR), Olguín, Hugo Juárez^3,4 (AUTHOR) juarezol@yahoo.com, Peraza, Armando Valenzuela¹ (AUTHOR), Ruíz, Norma Labra¹ (AUTHOR), Mejía, Gerardo Barragán² (AUTHOR)

Source: Scientific Reports. 5/12/2024, Vol. 14 Issue 1, p1-7. 7p.

Subject Terms: *ETOPOSIDE, *BRAIN damage, *CYTARABINE, *DOPAMINE, *BIOGENIC amines, *LABORATORY rats, *DOPAMINERGIC neurons

Oral Etoposide for Relapsed or Refractory Ewing Sarcoma in Adolescent and Adult Patients.

Authors: Kostos, Louise^1,2, Rayson, Victoria¹, Desai, Jayesh^1,2, Orme, Lisa^1,2, Bae, Susie^1,2, Hamilton, Anne^1,2, Luen, Stephen J.^1,2, Lewin, Jeremy^1,2,3, jeremy.lewin@petermac.org, Charan, Manish

Source: Sarcoma; 12/12/2024, Vol. 2024, p1-7, 7p

Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience.

Authors: Baude, Jérémy¹ (AUTHOR) jbaude@cgfl.fr, Niogret, Julie² (AUTHOR), Jacob, Pierre² (AUTHOR), Bardet, Florian³ (AUTHOR) florian.bardet@chu-dijon.fr, Desmoulins, Isabelle² (AUTHOR), Zanetta, Sylvie² (AUTHOR), Kaderbhai, Courèche² (AUTHOR), Galland, Loïck² (AUTHOR), Mayeur, Didier² (AUTHOR), Delattre, Benjamin³ (AUTHOR), Cormier, Luc^3,4 (AUTHOR), Ladoire, Sylvain^2,4,5,6 (AUTHOR) sladoire@cgfl.fr

Source: Cancers. Jan2024, Vol. 16 Issue 2, p280. 14p.

Subject Terms: *ETOPOSIDE, *ADENOCARCINOMA, *CARBOPLATIN, *METASTASIS, *RETROSPECTIVE studies, *TREATMENT effectiveness, *CANCER patients, *COMPARATIVE studies, *DESCRIPTIVE statistics, *NEUROENDOCRINE tumors, *PROGRESSION-free survival, *TUMOR markers, *PROSTATE-specific antigen, *ODDS ratio, *PROSTATE tumors

Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.

Authors: Mau-Sørensen, Morten¹, Gerner-Rasmussen, Jonas¹, Hansen, Olfred², Holm, Bente³, Nyhus, Christa Haugaard⁴, McCulloch, Tine⁵, Nielsen, Henrik Anker⁶, Wedervang, Kim⁷, Rytter, Carsten⁸, Jeppesen, Nina⁹, Langer, Seppo W.^1,10 seppo.langer@regionh.dk

Source: Acta Oncologica. Dec2023, Vol. 62 Issue 12, p1979-1982. 4p.

Subject Terms: *THERAPEUTIC use of antineoplastic agents, *ETOPOSIDE, *DRUG efficacy, *TOPOTECAN, *CONFIDENCE intervals, *SMALL cell carcinoma, *FISHER exact test, *PLATINUM, *TREATMENT effectiveness, *SURVIVAL rate, *SURVIVAL analysis (Biometry), *KAPLAN-Meier estimator, *DESCRIPTIVE statistics, *PROGRESSION-free survival, *OVERALL survival, *DRUG toxicity

Potentiation of Apoptotic Effect of Combination of Etoposide and Quercetin on HepG2 Liver Cancer Cells.

Authors: Aslani, Fereshteh¹, Afarin, Reza¹, Madiseh, Nafiseh Dehghani¹, Nasab, Hasti Beheshti¹, Monjezi, Sajad¹, Igder, Somayeh¹, Rashidi, Mojtaba² ms.rashiidii60@gmail.com

Source: Hepatitis Monthly. Dec2023, Vol. 23 Issue 1, p1-12. 12p.

Subject Terms: *ETOPOSIDE, *REVERSE transcriptase polymerase chain reaction, *PROTEINS, *COMBINATION drug therapy, *LIVER tumors, *STAINS & staining (Microscopy), *WESTERN immunoblotting, *APOPTOSIS, *B cell lymphoma, *QUERCETIN, *GENE expression, *DRUG synergism, *DESCRIPTIVE statistics, *RESEARCH funding, *CELL lines, *CASPASES, *PHARMACODYNAMICS

In‐vitro toxicity of cyclophosphamide and etoposide intermediates/metabolites produced by three white rot fungi.

Authors: Yadav, Ankush¹ (AUTHOR), Rene, Eldon R.² (AUTHOR), Mandal, Mrinal Kanti³ (AUTHOR), Dubey, Kashyap Kumar⁴ (AUTHOR) kashyapdubey@gmail.com

Source: Environmental Quality Management. Jun2023, Vol. 32 Issue 4, p311-316. 6p. 1 Chart, 1 Graph.

Subject Terms: Etoposide, Cyclophosphamide, Trametes versicolor, Phanerochaete chrysosporium, Ganoderma lucidum, Metabolites

Effect of metformin alone and in combination with etoposide and epirubicin on proliferation, apoptosis, necrosis, and migration of B-CPAP and SW cells as thyroid cancer cell lines.

Authors: Ghavami, Ghazaleh¹ (AUTHOR), Kiasari, Ebrahimi¹ (AUTHOR), Pakzad, Faezeh¹ (AUTHOR), Sardari, Soroush¹ (AUTHOR)

Source: Research in Pharmaceutical Sciences. Apr2023, Vol. 18 Issue 2, p185-201. 17p.

Subject Terms: *THYROID cancer, *ETOPOSIDE, *EPIRUBICIN, *CELL lines, *CELL migration, *METFORMIN, *CANCER cells

Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis.

Authors: Lee, Jerry C.¹ (AUTHOR) aaron.logan@ucsf.edu, Logan, Aaron C.¹ (AUTHOR)

Source: Cancers. Mar2023, Vol. 15 Issue 6, p1839. 22p.

Subject Terms: *ETOPOSIDE, *HEMOPHAGOCYTIC lymphohistiocytosis, *ADRENOCORTICAL hormones, *HETEROCYCLIC compounds, *METASTASIS, *LYMPHOMAS, *IMMUNOTHERAPY, *DISEASE complications, *ADULTS

Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.

Authors: Lin, Meng^1,2 (AUTHOR), Wu, Xiaolong^1,2 (AUTHOR), Zhang, Lei^1,2 (AUTHOR), Li, Ling^1,2 (AUTHOR), Wang, Xinhua^1,2 (AUTHOR), Fu, Xiaorui^1,2 (AUTHOR), Sun, Zhenchang^1,2 (AUTHOR), Zhang, Xudong^1,2 (AUTHOR), Zhu, Linan^1,2 (AUTHOR), Yu, Hui^1,2 (AUTHOR), Chang, Yu^1,2 (AUTHOR), Nan, Feifei^1,2 (AUTHOR), Yan, Jiaqin^1,2 (AUTHOR), Zhou, Zhiyuan^1,2 (AUTHOR), Shi, Cunzhen^1,2 (AUTHOR), Zhang, Mingzhi^1,2 (AUTHOR), Li, Xin^1,2 (AUTHOR)

Source: Leukemia & Lymphoma. Mar2023, Vol. 64 Issue 3, p605-612. 8p.

Subject Terms: *STEM cell transplantation, *ETOPOSIDE, *CYCLOPHOSPHAMIDE, *CYTARABINE, *HODGKIN'S disease

Evaluation of Possible Neobavaisoflavone Chemosensitizing Properties towards Doxorubicin and Etoposide in SW1783 Anaplastic Astrocytoma Cells.

Authors: Maszczyk, Mateusz¹ (AUTHOR), Banach, Klaudia¹ (AUTHOR), Rok, Jakub¹ (AUTHOR), Rzepka, Zuzanna¹ (AUTHOR), Beberok, Artur¹ (AUTHOR), Wrześniok, Dorota¹ (AUTHOR) dwrzesniok@sum.edu.pl

Source: Cells (2073-4409). Feb2023, Vol. 12 Issue 4, p593. 14p.

Subject Terms: *ASTROCYTOMAS, *ETOPOSIDE, *MITOCHONDRIAL membranes, *MEMBRANE potential, *THERAPEUTICS, *CELL death, *DOXORUBICIN, *FLAVONOIDS

Combinational Inhibition of P-Glycoprotein-Mediated Etoposide Transport by Zosuquidar and Polysorbate 20.

Authors: Nielsen, Rasmus Blaaholm¹ (AUTHOR), Holm, René¹ (AUTHOR), Pijpers, Ils² (AUTHOR), Snoeys, Jan³ (AUTHOR), Nielsen, Ulla Gro¹ (AUTHOR), Nielsen, Carsten Uhd¹ (AUTHOR) cun@sdu.dk

Source: Pharmaceutics. Jan2023, Vol. 15 Issue 1, p283. 19p.

Subject Terms: *SPRAGUE Dawley rats, *ETOPOSIDE, *DRUG absorption, *TRETINOIN, *SMALL molecules

Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas.

Authors: Sorigue, Marc¹ (AUTHOR) msorigue@iconcologia.net, Kuittinen, Outi^2,3,4 (AUTHOR)

Source: Cancers. Jan2023, Vol. 15 Issue 1, p220. 15p.

Subject Terms: *THERAPEUTIC use of monoclonal antibodies, *ETOPOSIDE, *HOMOGRAFTS, *CELLS, *HEMATOPOIETIC stem cell transplantation, *T-cell lymphoma, *RARE diseases, CENTRAL nervous system tumors

Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML.

Authors: Strachan, Debbie C.¹ (AUTHOR), Gu, Christine J.¹ (AUTHOR), Kita, Ryosuke¹ (AUTHOR), Anderson, Erica K.¹ (AUTHOR), Richardson, Michelle A.¹ (AUTHOR), Yam, George¹ (AUTHOR), Pimm, Graham¹ (AUTHOR), Roselli, Jordan¹ (AUTHOR), Schweickert, Alyssa¹ (AUTHOR), Terrell, Maci² (AUTHOR), Rashid, Raushan² (AUTHOR), Gonzalez, Alan K.² (AUTHOR), Oviedo, Hailey H.² (AUTHOR), Alozie, Michelle C.² (AUTHOR), Ilangovan, Tamilini² (AUTHOR), Marcogliese, Andrea N.³ (AUTHOR), Tada, Hiroomi¹ (AUTHOR), Santaguida, Marianne T.¹ (AUTHOR), Stevens, Alexandra M.² (AUTHOR) amsteven@txch.org

Source: Cancers. 12/15/2022, Vol. 14 Issue 24, p6240. 16p.

Subject Terms: *ETOPOSIDE, *FLOW cytometry, *CLINICAL drug trials, *INDIVIDUALIZED medicine, *PEDIATRICS, *ANTINEOPLASTIC agents, *DESCRIPTIVE statistics, *CYTARABINE, *DAUNOMYCIN

A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol.

Authors: Asao, Tetsuhiko¹ (AUTHOR), Watanabe, Satoshi² (AUTHOR) satoshi7@med.niigata-u.ac.jp, Tanaka, Takahiro³ (AUTHOR), Morita, Satoshi⁴ (AUTHOR), Kobayashi, Kunihiko⁵ (AUTHOR)

Source: BMC Cancer. 11/4/2022, Vol. 22 Issue 1, p1-6. 6p.

Subject Terms: *LUNG cancer, *ETOPOSIDE, *RESEARCH, *CLINICAL trials, *CARBOPLATIN, *LUNG tumors, *ANTINEOPLASTIC agents

Rare Case of Refractory Hypoxia and Severe Multiorgan Failure from Secondary Lymphohistiocytosis Successfully Bridged to Treatment with Extracorporeal Membrane Oxygenation Support.

Authors: Hundal, Jasmin¹, Bowers, David¹, Gadela, Naga Vaishnavi¹, Jaiswal, Abhishek² Jaiswal@hhchealth.org

Source: Indian Journal of Critical Care Medicine. Aug2022, Vol. 26 Issue 8, p970-973. 4p. 1 Diagram, 1 Chart.

Subject Terms: *ETOPOSIDE, *HEMOPHAGOCYTIC lymphohistiocytosis, *CHEST X rays, *FEVER, *EXTRACORPOREAL membrane oxygenation, *MULTIPLE organ failure, *ADULT respiratory distress syndrome, *SEVERITY of illness index, *COUGH, *RARE diseases, *HYPOXEMIA, *T-cell lymphoma

Life-Saving Effect of Corticosteroid and Colchicine Combination in Acute Myeloid Leukemia: Case Report.

Authors: Pbdolkarimi, Babak¹, Hashemieh, Mozhgan² mozhgan.hashemieh@yahoo.com, Amin, Prash³

Source: Middle East Journal of Cancer. Jul2022, Vol. 13 Issue 3, p556-563. 8p.

Subject Terms: *ETOPOSIDE, *FUROSEMIDE, *SPIRONOLACTONE, *COMBINATION drug therapy, *INTRAVENOUS therapy, *MITOXANTRONE, *PREDNISOLONE, *IMMUNOGLOBULINS, *COLONY-stimulating factors (Physiology), *PERICARDIAL effusion, *ANTINEOPLASTIC agents, *IDARUBICIN, *CYTARABINE, *THROMBOCYTOPENIA, *COLCHICINE

Chemosensitization of U-87 MG Glioblastoma Cells by Neobavaisoflavone towards Doxorubicin and Etoposide.

Authors: Maszczyk, Mateusz¹ (AUTHOR) d200888@365.sum.edu.pl, Banach, Klaudia¹ (AUTHOR), Karkoszka, Marta¹ (AUTHOR), Rzepka, Zuzanna¹ (AUTHOR), Rok, Jakub¹ (AUTHOR), Beberok, Artur¹ (AUTHOR), Wrześniok, Dorota¹ (AUTHOR) dwrzesniok@sum.edu.pl

Source: International Journal of Molecular Sciences. May2022, Vol. 23 Issue 10, p5621-5621. 12p.

Subject Terms: *ETOPOSIDE, *CHEMOSENSITIZERS, *DOXORUBICIN, *GLIOBLASTOMA multiforme, *ANTINEOPLASTIC agents, *ISOFLAVONES, *ANTHRACYCLINES, *MEMBRANE potential

Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals.

Authors: Chalumeau, Clelia¹ (AUTHOR) clelia.chalumeau@gmail.com, Carton, Matthieu² (AUTHOR) matthieu.carton@curie.fr, Eeckhoutte, Alexandre^3,4 (AUTHOR) alexandre.eeckhoutte@curie.fr, Ballet, Stelly⁵ (AUTHOR) stelly.ballet@curie.fr, Vincent-Salomon, Anne⁵ (AUTHOR) anne.salomon@curie.fr, Vuagnat, Perrine¹ (AUTHOR) francois-clement.bidard@curie.fr, Bellesoeur, Audrey⁶ (AUTHOR) audrey.bellesoeur@curie.fr, Pierga, Jean-Yves^6,7 (AUTHOR) jean-yves.pierga@curie.fr, Stern, Marc-Henri^3,4 (AUTHOR) marc-henri.stern@curie.fr, Bidard, Francois-Clement^1,8 (AUTHOR) florence.lerebours@curie.fr, Lerebours, Florence¹ (AUTHOR)

Source: Cancers. May2022, Vol. 14 Issue 9, pN.PAG-N.PAG. 11p.

Subject Terms: *THERAPEUTIC use of antineoplastic agents, *ETOPOSIDE, *SPECIALTY hospitals, *SEQUENCE analysis, *COMBINATION drug therapy, *ONCOGENES, *TRASTUZUMAB, *METASTASIS, *PATIENT satisfaction, *MEDICAL care costs, *TREATMENT effectiveness, *CANCER treatment, *BREAST tumors, *EVALUATION

Geographic Terms: FRANCE

Cisplatin and Etoposide with Concurrent Radiotherapy in Locally Advanced Thymic Carcinoma.

Authors: HANEDAN USLU, Gonca¹ drgoncahanedanuslu@hotmail.com, YILDIZ AKDENİZ, Çağlar², YEŞILIRMAK, Nihat³

Source: Turkish Journal of Oncology / Türk Onkoloji Dergisi. 2022, Vol. 37 Issue 2, p223-226. 4p.

Subject Terms: *ETOPOSIDE, *THYMUS tumors, *TREATMENT effectiveness, *CISPLATIN, *RADIOTHERAPY, *COMBINED modality therapy

KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.

Authors: Ma, Lan^1,2 (AUTHOR), Yin, Changqing¹ (AUTHOR), Zhang, Yi¹ (AUTHOR), Li, Jie¹ (AUTHOR), Shi, Liuzhi³ (AUTHOR), Zhou, Tong¹ (AUTHOR), Huang, Xixi¹ (AUTHOR), Liu, Yaqi¹ (AUTHOR), Cao, Jiawei¹ (AUTHOR), Wu, Guang¹ (AUTHOR), Gu, Haihua¹ (AUTHOR) haihuagu@wmu.edu.cn, He, Licai¹ (AUTHOR) helicai@wmu.edu.cn

Source: Biological Chemistry. May2024, Vol. 405 Issue 5, p341-349. 9p.

Subject Terms: *ETOPOSIDE, *PROTEOLYSIS, *CELL differentiation, *IMMUNOPRECIPITATION, *MYELOID cells, *PROTEIN-protein interactions